Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/6061
Title: Thrombomodulin is a Strong Predictor of Multiorgan Dysfunction Syndrome in Patients With Sepsis
Authors: Dunja Mihajlović 
Dajana Lendak 
Biljana Drašković 
Aleksandra Novakov Mikić
Gorana Mitić 
Tatjana Ćebović 
Snežana Brkić 
Keywords: endothelial dysfunction;hemostasis;hypercoagulability
Issue Date: 4-Jul-2015
Journal: Clinical and Applied Thrombosis/Hemostasis
Abstract: © The Author(s) 2013. Background: Biomarkers of endothelial dysfunction are not recommended for routine laboratory investigation of the outcome prognosis and prediction of the course of sepsis. Methods: A total of 60 patients who fulfilled the criteria for diagnosis of sepsis were included in our study. Development of multiorgan dysfunction syndrome (MODS) in the first 48 hours was assessed. Differences between groups of patients with sepsis were assessed by Mann-Whitney U test and by Kruskal-Wallis test. Logistic regression analysis was performed to test the joint effect of different predictors. Results: Level of thrombomodulin was significantly higher in group of patients with MODS than without MODS (P=.015). Levels of antithrombin (P=.026) and protein C (P=.035) were significantly lower in patients with MODS. Level of thrombomodulin was the strongest predictor in MODS development in first 48 hours (P=.028). Conclusion: The level of thrombomodulin not only was able to distinguish the severity of sepsis but also was a significant predictor of MODS development.
URI: https://open.uns.ac.rs/handle/123456789/6061
ISSN: 10760296
DOI: 10.1177/1076029613508600
Appears in Collections:MDF Publikacije/Publications

Files in This Item:
File SizeFormat
1076029613508600.pdf119.35 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

17
checked on May 10, 2024

Page view(s)

41
Last Week
12
Last month
2
checked on May 3, 2024

Download(s)

10
checked on May 3, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.